Jellagen closes £8.7m Series A funding round to accelerate development of Collagen Type 0 and revolutionise regenerative medicine
8 December 2022
Copner Biotech and Jellagen Ltd awarded Innovate UK funding to develop game-changing 3D Inkjet Bioprinting Platform
1 November 2022
Jellagen and Copner Biotech announce completion of world-first SMART Cymru-funded project supporting the development of a next-generation bioprinting system and innovative new jellyfish-derived bio-ink
29 September 2022
New partnership between Jellagen and Cellaria Inc. offers paradigm shift in collagen chemistry to develop nextgeneration models for cancer research
13 November 2021